Sunday November 22 2009 | Biotechnology feed | All feeds

BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease

Transgene

TRANSGENE is a leading integrated gene therapy company, dedicated to the discovery and development of gene delivery technologies and gene therapy products for the treatment of acquired and inherited diseases. The Company's proprietary technology platform consists of five vector families including three of viral origin - adenovirus, retrovirus, vaccinia virus - and two of non viral origin - cellular and synthetic vectors.


Contact Details:
11 rue de Molsheim
Strasbourg
F-67082
France
Tel:00 33 88 27 91 00
Fax:00 33 88 27 91 11
Email:
WWW:

www.transgene.fr/




Recent Publications by Transgene:

Solution structure of the complex of VEK-30 and plasminogen kringle 2.
The solution structure of the complex containing the isolated kringle 2...
6th October, 2009
W.M. Keck Center for Transgene Research, 230 Raclin-Carmichael Hall, J Struct Biol. 2009 Sep 30.
DOI Direct Link
The protein C pathway and pathologic processes.
Alterations in expression of protein C (PC) pathway components have been...
28th July, 2009
W. M. Keck Center for Transgene Research, and Department of Chemistry and J Thromb Haemost. 2009 Jul;7 Suppl 1:140-5.
DOI Direct Link
Adenovirus-mediated gene transfer of pathogen-associated molecular patterns for cancer immunotherapy.
The delivery of stimulatory signals to dendritic cells (DCs) in the tumor...
10th June, 2009
Molecular Immunology Department, Transgene, Strasbourg, France. Cancer Gene Ther. 2009 Apr;16(4):310-9. Epub 2008 Oct 24.
DOI Direct Link
ADP-ribosylation factor 6 regulates tumorigenic and invasive properties in vivo.
This study shows that the small GTP-binding protein ADP-ribosylation...
14th May, 2009
Department of Biological Sciences, Freimann Life Science Center, and W.M. Cancer Res. 2009 Mar 15;69(6):2201-9. Epub 2009 Mar 10.
DOI Direct Link
The selectivity of conantokin-G for ion channel inhibition of NR2B subunit-containing NMDA receptors is regulated by amino acid residues in the S2 region of NR2B.
The conantokins are short, naturally occurring peptides that inhibit ion...
12th May, 2009
W.M. Keck Center for Transgene Research and Department of Chemistry and Neuropharmacology. 2009 Aug;57(2):127-36. Epub 2009 May 8.
DOI Direct Link

View more Transgene research publications.

Press Releases on Transgene:

BioPortfolio Logo
New Report Just Published: World Hepatitis C Virus And Therapeutics Market Report 7th July, 2009 Reportlinker
NEW YORK, July 7 /PRNewswire/ -- Reportlinker.com just added a new market research report to its catalogue. World Hepatitis C Virus And Therapeutics Market http://www.reportlinker.com/p0119497/World
Caprion Proteomics Inc. and Applied Bioystems Work Together to Accelerate Protein Biomarker Verification and Validation 28th May, 2009 Caprion Proteomics Inc.
Combination of industry-leading services with unique QTRAP(R) technology MONTREAL, May 28 /PRNewswire/ -- Caprion Proteomics Inc. today announced that it is working with Applied Biosystems, a
The Institut Pasteur and Merieux Alliance Take First Step Towards a Long-Term Research Partnership in the Field of Infectious Diseases 18th May, 2009 The Institut Pasteur and Merieux Alliance
PARIS, May 18 /PRNewswire/ -- The Institut Pasteur and Merieux Alliance have signed a letter of intent for a long-term research partnership. The Institut Pasteur and Merieux Alliance (which
The Institut Pasteur and Mérieux Alliance Take First Step Towards a Long-Term Research Partnership in the Field of Infectious Diseases 18th May, 2009
PARIS, May 18 /PRNewswire/ -- The Institut Pasteur and Mérieux Alliance have signed a letter of intent for a long-term research partnership. The Institut Pasteur and Mérieux Alliance (which
Covance Purchases Equity Stake in Caprion Proteomics 16th December, 2008 Covance Inc.
- New Biomarker VP Appointed - Biomarker Center of Excellence Established in Greenfield, Indiana PRINCETON, N.J., Dec. 16 /PRNewswire-FirstCall/ -- Covance Inc. (NYSE: CVD), a leading provider of

BioNews Results for Transgene:

Transgene initiates enrollment in Phase I cancer trial
Individual.com:  Nov 9 2009 2:17PM Matching: transgene
Transgene: First Patient enrolled in Phase I Trial of TG4023 for
PharmiWeb:  Nov 6 2009 5:33AM Matching: transgene
Transgene: First Patient enrolled in Phase I Trial of TG4023 for the Treatment of Liver Tumours
Pharma Live:  Nov 5 2009 11:38AM Matching: transgene
Transgene: First Patient enrolled in Phase I Trial of TG4023 for the Treatment of Liver Tumours
Therapeutics Daily:  Nov 5 2009 1:49AM Matching: transgene
TRANSGENE : First patient enrolled in Phase I trial of TG4023 for the treatment of liver tumours
Individual.com:  Nov 5 2009 7:31AM Matching: transgene
Promote your company here: BioNewsCast - Press Release Distribution

View more Transgene news.

Transgene Clinical Trials:

Trial of TG4023 Combined With Flucytosine in Liver Tumors

Transgene Patents:

US Patent No.Title
6326350 Transferrin receptor subunit proteins of Neisseria meningitidis
6555377 Process for production of mammalian cell lines
6569677 Modified adenoviral fiber and target adenoviruses
6582694 Method for preparing a viral aerosol
6596533 Mutant having uracil phosphoribosyl transferase activity

View more Transgene patents.

Transgene (TRGNY) Financial information Links from Barchart

TRGNY Quote from from Barchart.com
TRGNY Chart from from Barchart.com
TRGNY Profile from from Barchart.com
TRGNY Opinion from from Barchart.com

View more Transgene finance information.

BioPortfolio Ltd provides targeted e-mail address lists for the life science sector - we can enable you to contact around 109 individuals from Transgene using this service.

Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.

This page has been viewed 789 times since April 2007, the link to the organisation's website has been followed 147 times

Recent Search Terms used to find this page: transgene strasbourg | transgene france | Transgene france | transgene france | transgene strasbourg | .

Search for more companies in Strasbourg

Search for more companies in



This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.
BioPortfolio search results for Transgene

 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.

All rights reserved. All other trademarks recognized.
Copyright 1997-2009 - BioPortfolio Limited.